Siena Capital’s West Pharmaceutical WST Stock Holding History

Siena Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25	Closed	-$8K	–	264
2022 Q2	$8K	Hold	25	–	–	﹤0.01%	185
2022 Q1	$10K	Buy	+25	New	+$9.79K	0.01%	218

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siena Capital's WST Position: Q3 2022 in Review

Siena Capital sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 25 shares — an estimated $8K sold.

Siena Capital first reported a position in WST in Q1 2022 and held it in 2 quarters. The position peaked at $10K in Q1 2022. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

Siena Capital reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
Siena Capital sold 25 West Pharmaceutical shares in Q3 2022, an estimated $8K.
Siena Capital first reported a position in West Pharmaceutical in Q1 2022 and held it in 2 quarters.
Siena Capital's West Pharmaceutical position peaked at $10K in Q1 2022.
638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.